U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5107620

Electrified Table Cloth

An electrified table cloth for preventing crawling insects from gaining access to the consumer's food or drink.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Attorney: Hale; Rebecca M.


Number of patents: 11
Last date: October 03, 2006

NumberTitleIssue Date
7115730Immunogenic detoxified mutant LT-A-toxin
An immunogenic detoxified protein is provided which comprises the amino acid sequence of subunit A of an E. coli heat labile toxin (LT-A) or a fragment thereof in which at least amino acid Ala-72, numbered relative to SEQ ID NO:1, of the A subunits mutated, p...
10/03/2006
7070791Detection of antibodies against pgp3 antigen in patient sera by enzyme-linked immunoassay
A new recombinant form of the plasmid-encoded protein pgp3 from C. trachomatis, serotype D, was purified by ion exchange column chromatography and shown to be suitable for quantitative immunoassy on clinical samples in an ELISA format. ...
07/04/2006
7056521Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
The present invention provides parenteral adjuvants comprising detoxified mutants of bacterial ADP-ribosylating toxins, particularly those from pertussis (PT), cholera (CT), and heat-labile E. coli (LT). ...
06/06/2006
7038012Enrichment process for neutrophil activating protein (NAP) utilizing metal chelate chromatography
The invention relates to a process for enriching the presence of H. pylori NAP in a mixture of proteins. The process involves salting-out other proteins. NAP has been found to remain soluble at ammonium sulphate concentrations of 80% and above. The process ma...
05/02/2006
6902903Helicobacter pylori diagnostics
Novel methods, membrane supports and immunodiagnostic test kits for diagnosing Helicobacter pylori infection, are disclosed. The methods can also be used to monitor the progress of treatment of an infection. The methods, supports and kits employ both type-com...
06/07/2005
6900302Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
The invention relates to peptide, oligopeptide or polypeptide compounds that are capable of eliciting a protective immune response against the capsular polysaccharide of group B Streptococcus (GBS), particularly type III GBS. Such compounds are useful in the ...
05/31/2005
6863896Plant lectins as mucosal adjuvants
The invention provides a method of increasing an immune response in a mammal. The method involves administering to the mammal an admixture comprising an immunogen and a plant lectin. The plant lectin acts as an adjuvant to increase an immune response against the imm...
03/08/2005
6855321Polyepitope carrier protein
The invention relates to polyepitope carrier proteins that comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides. The carrier proteins are use useful as components of vaccines that can elicit a T-cell dependent immune response. The...
02/15/2005
6841155Immunization against and treatment for infection by H. pylori
Methods for treating and/or protecting H. pylori infection are described. The methods utilize non-mucosal administration of an effective amount of one or more H. pylori antigens. ...
01/11/2005
6818222Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
The present invention provides parenteral adjuvants comprising detoxified mutants of bacterial ADP-ribosylating toxins, particularly those from pertussis (PT), cholera (CT), and heat-labile E. coli (LT). ...
11/16/2004
6676938Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates
The invention relates to peptide, oligopeptide or polypeptide compounds that are capable of eliciting a protective immune response against the capsular polysaccharide of group B Streptococcus (GBS), particularly type III GBS. Such compounds are useful in ...
01/13/2004
 
Sign InRegister
Username  
Password   
forgot password?